100+
paid subscribers
2K+
free subscribers

BowTiedBiotech

About the Substack

4-5x Weekly Biotech Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends

Free Subscription Benefits

  • WEEKLY biotech public/private market updates

Paid Subcription Benefits

  • INSIDER INSIGHTS to SHARPEN your stock picking & company building skills
  • TRADE BIOTECH STOCKS with material event alerts (data readouts, approvals)
  • GIVE to GET: Opportunity to support the hours we put into sharing our content

Paid Subscription Plans

  • $54.98 a year
  • $5.30 a month

About BowTiedBiotech

Weekly Biotech Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends

Is this your Substack? Request changes.

BowTiedBiotech's recommended Substacks

BowTied Bull logo
BowTied Bull

BowTied Bull

The #1 Paid Crypto Substack. No non-sense writing style covering: 1) Crypto, 2) Tech Stocks, 3) WiFi money and 4) Real Estate. Written by anon Ex-Wall St and Tech Individuals. SPONSOR FREE.

1000+
paid subscribers
95K+
free subscribers
Big Pharma Sharma logo
Big Pharma Sharma

Big Pharma Sharma

12+ year BioPharma strategy pro, facetiously named "Big Pharma Sharma". Delivering weekly insights, analyses, and takes here from an insider's perspective.

Asymmetric Learning - Pharmaceutical Innovation  logo
Mike Rea, IDEA Pharma

Asymmetric Learning - Pharmaceutical Innovation

Innovations in Pharmaceutical Innovation A blog/ part-work from Mike Rea, CEO of IDEA Pharma, exploring pharmaceutical innovation in general, and more specifically the approach to using the learning process for competitive advantage